Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LARS2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | IL10RA | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | HNRNPH3 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NSL1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | LINGO1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CD22 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | DKK2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | TFPI | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ABHD17C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | OSBPL10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |